Latest updates for Bayry

Fresh curated links around BAYRY are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Bayer Aktiengesellschaft (BAYRY) Q1 2026 Earnings Call Transcript
  • Bayer Aktiengesellschaft 2026 Q1 - Results - Earnings Call Presentation
  • <![CDATA[Pharma M&A Roundup: Bayer to Acquire Perfuse Therapeutics, Madrigal Enters Licensing Agreement for ARO-P

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

seekingalpha.com /2 weeks ago

Bayer Aktiengesellschaft (BAYRY) Q1 2026 Earnings Call Transcript

Read source
seekingalpha.com /2 weeks ago

Bayer Aktiengesellschaft 2026 Q1 - Results - Earnings Call Presentation

Read source
pharmexec.com /3 weeks ago

&lt;![CDATA[Pharma M&amp;A Roundup: Bayer to Acquire Perfuse Therapeutics, Madrigal Enters Licensing Agreement for ARO-P...

Read source
seekingalpha.com /1 week ago

ImmunityBio: Could Be One Approval Away From A Multi-Billion Dollar Breakout

Read source
finance.yahoo.com /1 month ago

Market Digest: BMY, SWX

Read source
finance.yahoo.com /1 month ago

Market Digest: BMY, SWX

Read source
seekingalpha.com /2 weeks ago

Ars Pharmaceuticals anticipates CVS Caremark decision as it expands $199 retail access program

Read source
finance.yahoo.com /1 month ago

Analyst Report: Roche Holding AG

Read source
finance.yahoo.com /1 month ago

Analyst Report: Bristol-Myers Squibb Co

Read source
finance.yahoo.com /1 month ago

Analyst Report: Bristol-Myers Squibb Co

Read source
seekingalpha.com /1 month ago

Protalix: Elfabrio Struggles Against Oral Competition

Read source
seekingalpha.com /1 month ago

Recursion Pharmaceuticals May Be Losing Ground To Its Peers

Read source
fool.com /1 month ago

Is Bristol Myers Squibb the Best Bargain in Big Pharma?

This pharma stock is cheap for a reason.

Read source
seekingalpha.com /2 weeks ago

Royalty Pharma: Strong Execution, Expanding Pipeline And More Firepower Ahead

Read source
seekingalpha.com /1 month ago

Merck KGaA (MKKGY) Presents at BNP Paribas Exane Healthcare Conference - Slideshow

Read source
seekingalpha.com /1 week ago

Apogee Therapeutics: Targeting Atopic Dermatitis

Read source
pharmexec.com /3 weeks ago

&lt;![CDATA[BioNTech Releases First Quarter Results for 2026 ]]&gt;

Read source
seekingalpha.com /2 weeks ago

ImmunityBio acquiring U.S. rights to Tokyo strain of BCG

Read source
seekingalpha.com /1 month ago

Syngenta is said to target resistant weeds with new herbicide in South America

Read source
pharmexec.com /3 weeks ago

&lt;![CDATA[UCB Enters $2.2 Billion Agreement to Acquire Candid Therapeutics ]]&gt;

Read source
seekingalpha.com /1 month ago

Revolution Medicines: PDAC Data Wows Wall Street - Jury's Out On Further Upside

Read source
pharmexec.com /3 weeks ago

&lt;![CDATA[Pharmaceutical Executive Daily: BioNTech Reports 2026 First Quarter Results]]&gt;

Read source
seekingalpha.com /1 month ago

Roche Holding AG (RHHBY) Q1 2026 Sales/Trading Call Transcript

Read source
fool.com /1 month ago

Which Dividend Pharma Stock Should a Value Investor Choose Today?

Bristol Myers Squibb looks like a value buy, so long as its pipeline remains strong.

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Bayry

seekingalpha.com

Recent coverage from public sources
Public source

finance.yahoo.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

fool.com

Recent coverage from public sources
Public source

pharmexec.com

Recent coverage from public sources
Public source